Published: 19 January, 2018 | Volume 2 - Issue 1 | Pages: 001-005
Figure 1:
Only 60.8 % (482/794) of the total subjects had titer above 10 miu/ml and were protected against Hepatitis B. Around 80.6% (246/305) of those who were fully vaccinated and only 40.8% (237/489) of those who were not vaccinated previously had protective anti-HBs titers(>10 miu/ml). Out of those 483 subjects who had protective anti-HBs titers, 121 (15.27%) had titers between 10-100 miu/ml while 203(25.5%) had titers above 1000 miu/ml. Majority (86.8%, 271/312) of those who had titer below 10 miu/ml were unvaccinated (Figure 1). One fourth of (2/8) employees who had history of needle stick injury in past were found non-immune to Hep-B infection and one individual was found to antiHBcore total positive. On further serological and molecular evaluation of this case we found him we found him chronic infective carrier (Table 2). Irrespective of history of vaccination, females were found to be more pretected than the males (241/374, 64% vs.242/420, 57%) (Figure 1).
Read Full Article HTML DOI: 10.29328/journal.jhcr.1001005 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."